Plasma Levels of Epinephrine and Norepinephrine Along with Expression Levels of 2-Adrenergic Receptor Gene as a ProbablePrognostic Factor of Acute GvHD
سال انتشار: 1397
نوع سند: مقاله کنفرانسی
زبان: انگلیسی
مشاهده: 327
نسخه کامل این مقاله ارائه نشده است و در دسترس نمی باشد
- صدور گواهی نمایه سازی
- من نویسنده این مقاله هستم
استخراج به نرم افزارهای پژوهشی:
شناسه ملی سند علمی:
NSCMRMED03_133
تاریخ نمایه سازی: 30 دی 1397
چکیده مقاله:
Background and Aim: Acute graft-versus-host disease (aGvHD) is themajor hindrance of allogeneic hematopoietic stem-cell transplantation(AHSCT). Epinephrine (E) and norepinephrine (NE) are adrenal glandsstress hormones which affect many cells include immune cells throughinteraction with adrenergic receptors mainly B2-adrenergic receptor (B2-AR). The immunomodulatory effects of E, NE and AR-signaling haveshown to decrease the probability of GvHD. The plasma levels of E andNE and the gene expression of B2-AR in leukocytes of patients who develop aGvHD with recipients without aGvHD have been comparedin this study.Method: The plasma samples were taken from 15 AHSCT candidatesAt days -7, 0, +7, and + 21 (day of transplantation was consideredas day 0) and the levels of E and NE were assayed by Enzyme-linkedimmunosorbent assay (ELISA). cDNA was reverse transcribed from buffycoats-extracted total RNA and the expression of B2-AR was measuredusing real-time PCR. The incidence of aGvHD was measured accordingto the patient s clinical manifestations and International criteria. Mann-Whitney U test was used to analyze data.Results: aGvHD were presented in 5 patients out of 15 patients during100 days post-AHSCT. The mean plasma levels of E and NE and also theexpression of B2-AR in leukocytes of aGvHD patients were significantlylower than non-aGvHD recipients. (P value <0.05).Conclusion: Regarding the lower levels of plasma E and NE and 2-ARexpression in aGvHD patients compared with recipients without aGvHD,we can conclude that the stress through hormones and their receptormight have a role in preventing aGvHD and could be a predictive markerfor aGvHD.
کلیدواژه ها:
نویسندگان
Zahra Momeni
Hematology and Oncology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
Mohammad Hossein Kazemi
Department of Immunology, Iran University of Medical Sciences, Tehran, Iran
Ghazaleh Sankanian
Hematopoeitic Stem Cell Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
Aliakbar Movassaghpour
Hematology and Oncology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran